Advertisement

Related Videos

Garth Strohbehn, MD, MPhil, on Applied Clinical Pharmacology in a Crisis: Interventional Pharmacoeconomics and COVID-19

S. Vincent Rajkumar, MD, on Cost-Effective Treatment of Multiple Myeloma

CS Pramesh, MS, FRCS, on Opportunities in India: A Perspective From a Low-Middle Income Country

Victoria T. Brown, PharmD, BCOP, on Payer Intervention: The Example of Abiraterone

Daniel Goldstein, MD: Interventional Pharmacoeconomics - Why and How

Advertisement

Advertisement




Jan
29
Today In Oncology
Proton Therapy Reirradiation in Recurrent Head and Neck Squamous Cell Carcinoma
Docetaxel as a Radiosensitizer in Cisplatin-Ineligible Patients With Locally Advanced Head and Neck Cancer
Radiotherapy vs Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma
Head and Neck Cancer Clinical Trials May Be Becoming Less Diverse Despite National Efforts
Enfortumab Vedotin in Previously Treated Advanced Head and Neck Cancer
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo